首页> 外国专利> Isolated Antibody that specifically binds to and induces the degradation of receptor - 3 of Human Fibroblast Growth Factor (fgfr-3), Fragment of fgfr-3 Link Human Same, Pharmaceutical Composition and resulting product

Isolated Antibody that specifically binds to and induces the degradation of receptor - 3 of Human Fibroblast Growth Factor (fgfr-3), Fragment of fgfr-3 Link Human Same, Pharmaceutical Composition and resulting product

机译:与人成纤维细胞生长因子(fgfr-3)的受体-3特异性结合并诱导其降解的分离抗体,fgfr-3片段片段与人类相同,药物组合物和所得产品

摘要

Isolated Antibody that specifically binds with the receptor - 3 of Human Fibroblast Growth Factor (fgfr-3) (b) and 3 (FGFR III c) or Mutant forms of fgfr-3 and induces the degradation of the receptor.Cdrh1 comprises a sequence that has gymftsygis (SEC ID no: 1), which has a cdrh2 sequence wvstyngdtnyaqkfqg (SEC ID: 2 NS), which has a cdrh3 sequence vlgyydsidgyyygmdv (SEC ID no: 3), is a cdrl1 sequence ggnnigdksvh (SEC ID no: 4), a cdrl2 that the sequence LDT ERPs (sec. Id: 5 NS), and has a cdrl3 sequence qvwdsgsdhvv (SEC ID no: 6).Link Fragment of Human that fgfr-3 Antibody. Pharmaceutical composition containing same. Product containing Said monoclonal antibody or Fragment. Its use as a Medicine to treat cancer.
机译:与人成纤维细胞生长因子(fgfr-3)(b)和3(FGFR I​​II c)的受体3或fgfr-3突变体形式特异性结合并诱导受体降解的分离抗体.Cdrh1包含一个序列具有gymftsygis(SEC ID号:1),其具有cdrh2序列wvstyngdtnyaqkfqg(SEC ID:2 NS),具有cdrh3序列vlgyydsidgyyygmdv(SEC ID号:3),是cdrl1序列ggnnigdksvh(SEC ID号:4) ,是一个序列LDT ERPs(秒ID:5 NS)的cdrl2,并具有一个cdrl3序列qvwdsgsdhvv(SEC ID号:6)。fgfr-3抗体的人类片段。包含相同的药物组合物。包含所述单克隆抗体或片段的产品。它用作治疗癌症的药物。

著录项

  • 公开/公告号AR073770A1

    专利类型

  • 公开/公告日2010-12-01

    原文格式PDF

  • 申请/专利权人 IMCLONE LLC.;

    申请/专利号AR2009P103832

  • 发明设计人

    申请日2009-10-05

  • 分类号C07K16/18;C07K16/30;A61K39/395;A61P35/00;

  • 国家 AR

  • 入库时间 2022-08-21 18:07:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号